Rhythm

Biosense Webster’s First Dual Energy Catheter to Treat Atrial Fibrillation Begins Evaluation in SmartfIRE Clinical Trial

Study will evaluate THERMOCOOL SMARTTOUCH™ SF Dual Energy Catheter’s potential to enable safer and simpler procedures with the ability to deliver both radiofrequency and pulsed field ablation Irvine, CA – March 7, 2023 – Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced […]

Powerful Medical Launches PMcardio in the UK, Empowering Healthcare Professionals to Diagnose and Treat Cardiovascular Diseases with AI

LONDON, March 07, 2023 (GLOBE NEWSWIRE) — Powerful Medical is thrilled to announce the release of PMcardio, a revolutionary clinical assistant powered by artificial intelligence in the United Kingdom. The unique medical device in the form of a smartphone application empowers healthcare professionals to diagnose and treat 38 cardiovascular diseases from […]

Large Real-World Evidence Analysis Demonstrates that Zio® XT Is Associated With the Highest Diagnostic Yield, Lowest Retesting Rates, and Fastest Time to Clinical Diagnosis Compared to Other Ambulatory ECG Monitors

Additional studies presented at ACC.23/WCC reinforce the clinical value of the Zio suite of products and services SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent disease, recently presented the results of multiple new […]

Medtronic PulseSelect PFA System demonstrates impressive results in landmark PULSED AF global IDE trial

ACC.23/WCC late-breaking data: PULSED AF, one of the most rigorously executed PFA clinical studies to date, exceeds safety and efficacy performance goals in the treatment of paroxysmal and persistent atrial fibrillation DUBLIN and NEW ORLEANS, March 6, 2023 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its PulseSelect™ Pulsed Field […]

Viz.ai Announces Agreement with Bristol Myers Squibb to Enable Earlier Detection and Management of Suspected Hypertrophic Cardiomyopathy (HCM)

Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm intended to identify and triage patients suspected with HCM SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, a leader in AI-powered disease detection and care coordination, today announced a multi-year agreement with Bristol Myers Squibb (NYSE: BMY), a global biopharmaceutical company, […]

New Data Showcasing vMap’s Utility to Map Complex Arrhythmias to be Presented at American College of Cardiology 2023

Case studies highlighting vMap’s effectiveness at localizing arrhythmia termination sites in complex cases to be presented alongside vMap time study NEW ORLEANS–(BUSINESS WIRE)–Vektor Medical, developer of vMap® — the world’s first FDA-cleared technology to localize arrhythmias from just 12-lead ECG data — will present complex case studies that expand vMap’s utility […]

Implicity Releases SMART on FHIR App

New app improves cardiac remote monitoring workflows by providing clinicians access to Implicity alerts and reports directly within Epic’s electronic medical records systems.  CAMBRIDGE, Mass., March 2, 2023 /PRNewswire/ — Implicity®, a leader in remote patient monitoring (RPM) and cardiac data management solutions, released a new SMART on FHIR application to improve interoperability and […]

Lohman Technologies’ latest HomECG+ device promotes health equity with ease of use and embedded cellular technology

The latest version of the HomECG+ helps close the health equity gap by providing access to care for all patient types, including rural health, underserved populations, geographic disparities, and low-income populations. MILWAUKEE, March 2, 2023 /PRNewswire/ — Lohman Technologies recently announced the release of their 2.0, next-generation, HomECG+ product. The FDA-cleared, clinical-grade […]

Vivalink’s Biometrics Data Platform Supports UCSF Clinical Trial for Hypertrophic Cardiomyopathy (HCM)

The six-month EXCITE-HCM study of 70 patients will study the effects of exercise on electrical activity and blood flow using Vivalink’s medical wearable ECG sensor and cloud data services. CAMPBELL, Calif., March 1, 2023 /PRNewswire/ — UC San Francisco (UCSF) is conducting a six-month clinical trial on hypertrophic cardiomyopathy (HCM) using Vivalink‘s Biometrics Data Platform. […]

New Heart Health Education Components Arrive on OMRON Connect Mobile App

OMRON Healthcare celebrates Heart Health Month with new education components providing tips for AFib identification, quality sleep, healthy recipes, and lifestyle changes that may help reduce heart attack and stroke risk HOFFMAN ESTATES, Ill., Feb. 28, 2023 /PRNewswire/ — Global heart health leader OMRON Healthcare is celebrating Heart Health Month with new […]